Evidence map›Paper›PMID 21937949›Full record

ArticleShock (Augusta, Ga.)2011

Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal muscle of mice.

Hyung-yul Lee, Masao Kaneki, Jonathan Andreas, Ronald G Tompkins, J A Jeevendra Martyn

Abstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Erythropoietin Alleviates Burn-induced Muscle Wasting.International journal of medical sciences · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome.American journal of physiology. Heart and circulatory physiology · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hyung-yul LeeDepartment of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Masao Kaneki
Jonathan Andreas
Ronald G Tompkins
J A Jeevendra Martyn
Massachusetts General Hospital · USHarvard University · USShriners Hospitals for Children - Erie · US

Funding

MOLECULAR PHARMACOLOGY OF INSULIN RESISTANCE IN BURNSR01GM055082 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MARTYN, JEEVENDRA · 1997 to 2011
$3.3M
NIGMS NIH HHS GM055082NIGMS NIH HHS GM 25000NIGMS NIH HHS R01 GM055082
6 · The paper itself

Abstract

This study tested the hypothesis that a novel mitochondria-targeted SS-31 peptide attenuates the burn injury-induced apoptosis and endoplasmic reticulum stress and improves insulin sensitivity in the skeletal muscle. Following 30% total body surface area burn or sham burn, mice were injected daily with SS-31 peptide (5 mg/kg body weight), and the rectus abdominis muscles collected on postburn days 1, 3, and 7. The tissues were subjected to various biochemical and immunohistochemical analyses. Treatment with SS-31 peptide prevented burn-induced increases in the caspase 3 activity (P < 0.05) and apoptosis (P < 0.01) on postburn day 7. The SS-31 peptide treatment also prevented the increase in the expression levels of phosphatase and tensin homolog on postburn days 3 and 7. Burn injury-induced increases in the levels of two endoplasmic reticulum stress markers, binding immunoglobulin protein and protein disulfide isomerase, were significantly decreased by the SS-31 peptide treatments on postburn day 7 and on day 3 for binding immunoglobulin protein as well (P < 0.05). The effects of SS-31 appear to be, in part, due to its ability to reduce oxidative stress in burned mice, evidenced by reduced expression of oxidized proteins that were clearly evident on postburn day 7. Our results demonstrate a possible therapeutic potential of SS-31 peptide to ameliorate the adverse effects of burn injury in skeletal muscle.

Indexed as

AnimalsAntioxidantsApoptosisBurnsEndoplasmic Reticulum StressMaleMiceMice, Inbred C57BLMitochondriaMuscle, SkeletalOligopeptidesReactive Oxygen SpeciesAntioxidantsarginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamideOligopeptidesReactive Oxygen Species

Identifiers

PMID21937949
PMCPMC3230221
OpenAlexW2313950398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.